Company snapshot
Market Cap
$2B
Mid-cap2016 — today
10-Year Price
+136%
2016 — today
52-Week Range
$12.74$16.66
Current $16.51· 96%
Featured in rankings
Most Undervalued Healthcare StocksBest Healthcare Dividend StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth Stocks
Rankings recomputed after each US market close — see where SEM stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | 8.8 | — |
| ZTSZoetis Inc. | 13.0 | 2.7% |
| CNCCentene Corporation | 23.5 | — |
| ALCAlcon Inc. | 54.7 | 0.5% |
| RVMDRevolution Medicines, Inc. | -21.5 | — |
| ONCBeOne Medicines Ltd. | 5.1 | — |
| IDXXIDEXX Laboratories, Inc. | 40.8 | — |
| TEVATeva Pharmaceutical Industries Limited | 69.1 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
15.1
Near historic high
Near historic highs — last 10 years
Sector median 25.4below sector
P/B ratio
1.0
Historically cheap
Historically cheap relative to the last 10 years
Sector median 2.3below sector
EV / EBITDA
9.7
Above average
Pricier than usual over the last 10 years
Sector median 15.7below sector
Dividend Yield
1.5%
Below average
Below the 10-year average
Sector median 1.9%below sector
FCF Yield
5.8%
Historically low
Historically low relative to the last 10 years
Sector median -12.6%above sector